Colgate-Palmolive (NYSE:CL) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its holdings in Colgate-Palmolive (NYSE:CL) by 3.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,732,011 shares of the company’s stock after acquiring an additional 136,766 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.58% of Colgate-Palmolive worth $430,187,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Schechter Investment Advisors LLC increased its holdings in shares of Colgate-Palmolive by 6.0% in the fourth quarter. Schechter Investment Advisors LLC now owns 2,811 shares of the company’s stock valued at $256,000 after purchasing an additional 158 shares during the last quarter. Meridian Wealth Management LLC increased its stake in shares of Colgate-Palmolive by 9.5% in the 4th quarter. Meridian Wealth Management LLC now owns 11,953 shares of the company’s stock worth $1,087,000 after acquiring an additional 1,040 shares during the last quarter. Fidelis Capital Partners LLC raised its holdings in shares of Colgate-Palmolive by 9.8% during the 4th quarter. Fidelis Capital Partners LLC now owns 15,171 shares of the company’s stock worth $1,320,000 after acquiring an additional 1,359 shares during the period. LGT Fund Management Co Ltd. boosted its position in shares of Colgate-Palmolive by 294.8% during the 4th quarter. LGT Fund Management Co Ltd. now owns 41,756 shares of the company’s stock valued at $3,796,000 after acquiring an additional 31,179 shares during the last quarter. Finally, DJE Kapital AG purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $101,597,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 1.9 %

Colgate-Palmolive stock opened at $91.09 on Wednesday. The firm has a market capitalization of $73.92 billion, a P/E ratio of 25.88, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock’s fifty day simple moving average is $88.73 and its 200-day simple moving average is $95.29.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CL. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. Morgan Stanley cut their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.